Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.21.1
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Revenue $ 0 $ 0
Operating expenses:    
Research and development 1,456 1,142
Sales and marketing 711 51
Depreciation 91 71
General and administrative 2,972 2,011
Total operating expenses 5,230 3,275
Loss from operations (5,230) (3,275)
Other income:    
Interest income 53 4
Total other income 53 4
Net loss $ (5,177) $ (3,271)
Net loss per common share, basic and diluted (in dollars per share) $ (0.25) $ (0.19)
Weighted average number of common shares outstanding, basic and diluted 21,121,024 16,781,210